Welcome to another enlightening episode of "The Brand Called You," where host Ashutosh Garg sits down with Justin Byers, Founder and CEO of Axio BioPharma. Axio is a pioneering AI biomanufacturing company, transforming how monoclonal antibodies and biologics are developed and produced by integrating artificial intelligence and machine learning into drug design and manufacturing processes.

In this episode, Justin Byers shares his unique journey from scientist to entrepreneur, the inefficiencies he noticed in traditional biomanufacturing, and how Axio BioPharma accelerates drug development timelines, reduces risk, and ensures regulatory compliance—all while respecting data privacy. Discover how cross-functional teams, AI-driven predictive modeling, and federated data systems are creating real impact in healthcare, making treatments more accessible and paving the way for innovation in rare disease therapies.

Whether you're interested in biotech innovation, AI applications in healthcare, or the future of drug manufacturing and delivery, this conversation is filled with valuable insights and practical lessons.